These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37580503)

  • 1. Identification and synthesis of (Z)-3'-hydroxy clomiphene as a new potential doping-relevant metabolite of clomiphene.
    Euler L; Mürdter T; Heinkele G; Schwab M; Miller GD; Eichner D; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2023 Sep; 37(17):e9599. PubMed ID: 37580503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches.
    Euler L; Gillard N; Delahaut P; Pierret G; Mürdter T; Schwab M; Döhmen G; Thomas A; Thevis M
    Anal Chim Acta; 2022 Apr; 1202():339661. PubMed ID: 35341524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.
    Lu J; He G; Wang X; Xu Y; Wu Y; Dong Y; He Z; Liu X; Bo T; Ouyang G
    J Chromatogr A; 2012 Jun; 1243():23-32. PubMed ID: 22579489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens.
    Seyerlein L; Gillard N; Delahaut P; Pierret G; Thomas A; Thevis M
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2021 Nov; 38(11):1875-1882. PubMed ID: 34266369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for clomiphene in keratinous matrices using LC-MS/MS in doping purpose: Is a single intake of clomiphene detectable in hair and nail clippings?
    Gheddar L; Ameline A; Arbouche N; Blanchot A; Raul JS; Kintz P
    J Pharm Biomed Anal; 2024 Feb; 239():115888. PubMed ID: 38096632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of clomiphene metabolite isomers in human plasma by rapid-resolution liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Ganchev B; Heinkele G; Kerb R; Schwab M; Mürdter TE
    Anal Bioanal Chem; 2011 Jul; 400(10):3429-41. PubMed ID: 21533795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application.
    Gessner L; Thevis M; Rothschild MA; Jübner M
    Drug Test Anal; 2022 Oct; 14(10):1744-1761. PubMed ID: 35947101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
    Beuck S; Sigmund G; Koch A; Schänzer W; Pokrywka A; Kwiatkowska D; Thevis M
    Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
    Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
    Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes.
    Wagener F; Guddat S; Görgens C; Angelis YS; Petrou M; Lagojda A; Kühne D; Thevis M
    Anal Bioanal Chem; 2022 Jan; 414(2):1151-1162. PubMed ID: 34734312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Liquid Chromatography--Tandem Mass Spectrometry to Quantify and Confirm the Fentanyl Metabolite N-[1-(2-Phenethy-4-Piperidinyl)] Maloanilinic Acid in Equine Urine for Doping Control.
    You Y; Proctor RM; Haughan J; Missanelli JR; Robinson MA
    J Anal Toxicol; 2023 Apr; 47(4):393-402. PubMed ID: 36760176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry.
    Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT
    Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration.
    Ameline A; Gheddar L; Raul JS; Kintz P
    J Pharm Biomed Anal; 2022 Apr; 212():114660. PubMed ID: 35182830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
    Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
    Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
    Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
    Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T; Ahrens B
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.